Chinese medical reform fiscal measures have lined the pockets of hospitals and companies but not done much toward advancing China’s health care system, experts said on Wednesday, reports the state news agency Xinhua.
Since restructuring measures began in 2009, medical spending has increased by more than 20% annually. The central government has earmarked another increase for personal health care for 2015, which will provide urban and rural citizens with 360 renminbi ($58.90) of coverage, according to the government's five-year plan.
Yet, despite financial injections from the government, it is far from enough to cover the medical needs of many citizens, according to a medical reform bluebook released Tuesday by the Chinese Academy of Social Sciences (CASS) and the Social Sciences Academic Press.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze